Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q127280158
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241120235957.0 |
008
|
|
|
241120nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q127280158
|
035
|
|
|
‡a
(OCoLC)Q127280158
|
100
|
0 |
|
‡a
Larissa Ragozo Cardoso de Oliveira
‡c
researcher
‡9
en
|
670
|
|
|
‡a
Author's Analysis of the expression of toll-like receptors 2 and 4 and cytokine production during experimental Leishmania chagasi infection.
|
670
|
|
|
‡a
Author's Analysis of Toll-like receptors, iNOS and cytokine profiles in patients with pulmonary tuberculosis during anti-tuberculosis treatment.
|
670
|
|
|
‡a
Author's Benznidazole affects expression of Th1, Th17 and Treg cytokines during acute experimental Trypanosoma cruzi infection.
|
670
|
|
|
‡a
Author's C57BL/6 and DBA/1 Mice Differ in Their Response to Supplementation with 1,25D and Paricalcitol
|
670
|
|
|
‡a
Author's Calcitriol Prevents Neuroinflammation and Reduces Blood-Brain Barrier Disruption and Local Macrophage/Microglia Activation
|
670
|
|
|
‡a
Author's Calming Down Mast Cells with Ketotifen: A Potential Strategy for Multiple Sclerosis Therapy?
|
670
|
|
|
‡a
Author's Cloxacillin control of experimental arthritis induced by SEC(+) Staphylococcus aureus is associated with downmodulation of local and systemic cytokines.
|
670
|
|
|
‡a
Author's Cytokine Polymorphisms, Their Influence and Levels in Brazilian Patients with Pulmonary Tuberculosis during Antituberculosis Treatment
|
670
|
|
|
‡a
Author's DNA damage and nitric oxide production in mice following infection with L. chagasi
|
670
|
|
|
‡a
Author's DNA damage in BALB/c mice infected with Lacazia loboi and its relation to nutritional status
|
670
|
|
|
‡a
Author's DNA damage in peripheral blood mononuclear cells of patients undergoing anti-tuberculosis treatment
|
670
|
|
|
‡a
Author's Organic Selenium Reaches the Central Nervous System and Downmodulates Local Inflammation: A Complementary Therapy for Multiple Sclerosis?
|
670
|
|
|
‡a
Author's Selenization of S. cerevisiae increases its protective potential in experimental autoimmune encephalomyelitis by triggering an intestinal immunomodulatory loop
|
919
|
|
|
‡a
dnadamageinperipheralbloodmononuclearcellsofpatientsundergoingantituberculosistreatment
‡A
DNA damage in peripheral blood mononuclear cells of patients undergoing anti-tuberculosis treatment
‡9
1
|
919
|
|
|
‡a
analysisoftheexpressionoftolllikereceptors2and4andcytokineproductionduringexperimentalleishmaniachagasiinfection
‡A
Analysis of the expression of toll-like receptors 2 and 4 and cytokine production during experimental Leishmania chagasi infection.
‡9
1
|
919
|
|
|
‡a
calcitriolpreventsneuroinflammationandreducesbloodbrainbarrierdisruptionandlocalmacrophagemicrogliaactivation
‡A
Calcitriol Prevents Neuroinflammation and Reduces Blood-Brain Barrier Disruption and Local Macrophage/Microglia Activation
‡9
1
|
919
|
|
|
‡a
analysisoftolllikereceptorsinosandcytokineprofilesinpatientswithpulmonarytuberculosisduringantituberculosistreatment
‡A
Analysis of Toll-like receptors, iNOS and cytokine profiles in patients with pulmonary tuberculosis during anti-tuberculosis treatment.
‡9
1
|
919
|
|
|
‡a
benznidazoleaffectsexpressionofth1th17andtregcytokinesduringacuteexperimentaltrypanosomacruziinfection
‡A
Benznidazole affects expression of Th1, Th17 and Treg cytokines during acute experimental Trypanosoma cruzi infection.
‡9
1
|
919
|
|
|
‡a
c57bl6anddba1micedifferintheirresponsetosupplementationwith125dandparicalcitol
‡A
C57BL/6 and DBA/1 Mice Differ in Their Response to Supplementation with 1,25D and Paricalcitol
‡9
1
|
919
|
|
|
‡a
cytokinepolymorphismstheirinfluenceandlevelsinbrazilianpatientswithpulmonarytuberculosisduringantituberculosistreatment
‡A
Cytokine Polymorphisms, Their Influence and Levels in Brazilian Patients with Pulmonary Tuberculosis during Antituberculosis Treatment
‡9
1
|
919
|
|
|
‡a
calmingdownmastcellswithketotifenapotentialstrategyformultiplesclerosistherapy
‡A
Calming Down Mast Cells with Ketotifen: A Potential Strategy for Multiple Sclerosis Therapy?
‡9
1
|
919
|
|
|
‡a
dnadamageandnitricoxideproductioninmicefollowinginfectionwith50chagasi
‡A
DNA damage and nitric oxide production in mice following infection with L. chagasi
‡9
1
|
919
|
|
|
‡a
organicseleniumreachesthecentralnervoussystemanddownmodulateslocalinflammationacomplementarytherapyformultiplesclerosis
‡A
Organic Selenium Reaches the Central Nervous System and Downmodulates Local Inflammation: A Complementary Therapy for Multiple Sclerosis?
‡9
1
|
919
|
|
|
‡a
selenizationofscerevisiaeincreasesitsprotectivepotentialinexperimentalautoimmuneencephalomyelitisbytriggeringanintestinalimmunomodulatoryloop
‡A
Selenization of S. cerevisiae increases its protective potential in experimental autoimmune encephalomyelitis by triggering an intestinal immunomodulatory loop
‡9
1
|
919
|
|
|
‡a
cloxacillincontrolofexperimentalarthritisinducedbysec+staphylococcusaureusisassociatedwithdownmodulationoflocalandsystemiccytokines
‡A
Cloxacillin control of experimental arthritis induced by SEC(+) Staphylococcus aureus is associated with downmodulation of local and systemic cytokines.
‡9
1
|
919
|
|
|
‡a
dnadamageinbalb100miceinfectedwithlacazialoboianditsrelationtonutritionalstatus
‡A
DNA damage in BALB/c mice infected with Lacazia loboi and its relation to nutritional status
‡9
1
|
996
|
|
|
‡2
ISNI|0000000070634931
|
996
|
|
|
‡2
ISNI|0000000066452000
|
996
|
|
|
‡2
LC|n 2001064978
|
996
|
|
|
‡2
ISNI|0000000069016255
|
996
|
|
|
‡2
SUDOC|190079665
|
996
|
|
|
‡2
ISNI|0000000030935924
|
996
|
|
|
‡2
BLBNB|001561189
|
996
|
|
|
‡2
LC|no2010040152
|
996
|
|
|
‡2
LC|n 88038386
|
996
|
|
|
‡2
LC|n 2023001882
|
996
|
|
|
‡2
BLBNB|001590719
|
996
|
|
|
‡2
SUDOC|254919332
|
996
|
|
|
‡2
NUKAT|n 2017154515
|
996
|
|
|
‡2
PTBNP|48666
|
996
|
|
|
‡2
BLBNB|000473795
|
996
|
|
|
‡2
SUDOC|165905417
|
996
|
|
|
‡2
DNB|1249727545
|
996
|
|
|
‡2
ISNI|0000000077570870
|
996
|
|
|
‡2
NTA|073925985
|
996
|
|
|
‡2
BIBSYS|90123752
|
996
|
|
|
‡2
PTBNP|48672
|
996
|
|
|
‡2
RERO|A003654873
|
996
|
|
|
‡2
NUKAT|n 2002068058
|
996
|
|
|
‡2
DNB|1158030916
|
996
|
|
|
‡2
LC|no2015152866
|
996
|
|
|
‡2
ISNI|0000000034104837
|
996
|
|
|
‡2
BLBNB|000539156
|
996
|
|
|
‡2
NSK|000279175
|
996
|
|
|
‡2
DNB|1197919147
|
996
|
|
|
‡2
BLBNB|001418832
|
996
|
|
|
‡2
LC|n 2020250625
|
996
|
|
|
‡2
NTA|148609074
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|